SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

TAGLIATI, Federico
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.100
AS - Asia 5.025
EU - Europa 2.696
SA - Sud America 716
AF - Africa 120
Continente sconosciuto - Info sul continente non disponibili 118
OC - Oceania 8
Totale 18.783
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.884
SG - Singapore 1.866
CN - Cina 1.350
DE - Germania 600
VN - Vietnam 592
BR - Brasile 557
UA - Ucraina 432
IT - Italia 417
HK - Hong Kong 370
GB - Regno Unito 302
TR - Turchia 264
FI - Finlandia 239
FR - Francia 164
RU - Federazione Russa 134
SE - Svezia 133
BD - Bangladesh 127
JP - Giappone 119
CA - Canada 101
IN - India 95
PL - Polonia 84
MX - Messico 70
AR - Argentina 62
ID - Indonesia 43
ZA - Sudafrica 42
IQ - Iraq 37
NL - Olanda 34
BE - Belgio 30
PK - Pakistan 30
ES - Italia 29
EC - Ecuador 22
LT - Lituania 19
UZ - Uzbekistan 19
AT - Austria 18
VE - Venezuela 18
CO - Colombia 17
CL - Cile 15
EG - Egitto 15
DZ - Algeria 13
JM - Giamaica 13
PH - Filippine 13
SA - Arabia Saudita 13
JO - Giordania 11
KE - Kenya 11
IE - Irlanda 9
MA - Marocco 9
TN - Tunisia 9
CH - Svizzera 8
LB - Libano 8
TW - Taiwan 8
UY - Uruguay 8
AL - Albania 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
BO - Bolivia 6
IR - Iran 6
MY - Malesia 6
NP - Nepal 6
PY - Paraguay 6
AZ - Azerbaigian 5
TT - Trinidad e Tobago 5
BG - Bulgaria 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
HN - Honduras 4
KZ - Kazakistan 4
PE - Perù 4
PS - Palestinian Territory 4
AM - Armenia 3
CR - Costa Rica 3
DK - Danimarca 3
ET - Etiopia 3
EU - Europa 3
GR - Grecia 3
GT - Guatemala 3
IL - Israele 3
LV - Lettonia 3
MD - Moldavia 3
PR - Porto Rico 3
PT - Portogallo 3
RO - Romania 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
SV - El Salvador 3
TH - Thailandia 3
CY - Cipro 2
GA - Gabon 2
KG - Kirghizistan 2
ML - Mali 2
OM - Oman 2
PA - Panama 2
SY - Repubblica araba siriana 2
TG - Togo 2
UG - Uganda 2
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
Totale 18.648
Salva come PNG Salva come JPEG
Città #
Ashburn 1.466
Singapore 1.267
Woodbridge 890
Fairfield 716
San Jose 703
Chandler 565
Houston 526
Jacksonville 493
Beijing 445
Santa Clara 417
Ann Arbor 380
Hong Kong 356
Seattle 300
Wilmington 266
Cambridge 215
Ho Chi Minh City 191
Los Angeles 178
Addison 150
New York 150
Munich 145
Hanoi 138
Nanjing 137
Izmir 134
Dallas 128
Ferrara 120
Tokyo 118
Princeton 99
Lauterbourg 91
Helsinki 88
Boardman 86
Milan 83
Shanghai 80
Warsaw 78
Council Bluffs 72
Dearborn 67
São Paulo 64
San Diego 60
Turku 54
Orem 51
Mexico City 48
Shenyang 44
Bremen 41
Buffalo 41
Tianjin 39
Brooklyn 37
Nanchang 36
London 34
Da Nang 32
Denver 32
Montreal 32
Atlanta 31
Changsha 31
Chicago 30
Hebei 29
Johannesburg 29
Brussels 28
Chennai 28
Haiphong 28
Toronto 28
Washington 28
Frankfurt am Main 26
Hefei 25
Jinan 25
Jakarta 24
Manchester 24
Mountain View 24
Nuremberg 22
Jiaxing 21
Kunming 20
Tappahannock 19
Amsterdam 18
Boston 18
Guangzhou 18
Phoenix 18
Baghdad 17
Poplar 17
Rome 17
San Francisco 17
Hải Dương 16
Moscow 16
Stockholm 16
Tashkent 16
Ankara 15
Falls Church 15
Norwalk 15
Brasília 14
Biên Hòa 13
City of London 13
Falkenstein 13
Rio de Janeiro 13
Verona 13
Belo Horizonte 12
Redwood City 12
Amman 11
Auburn Hills 11
Charlotte 11
Leawood 11
Bologna 10
Indiana 10
Mumbai 10
Totale 12.929
Salva come PNG Salva come JPEG
Nome #
SRC homology-2-containing protein tyrosine phosphatase-1 restrains cell proliferation in human medullary thyroid carcinoma 435
Effect of Everolimus on Cell Viability in Nonfunctioning Pituitary Adenomas 289
Proposal for a novel management of indeterminate thyroid nodules on the basis of cytopathological subclasses 281
Role of Ultrasonographic/Clinical Profile, Cytology, and BRAF V600E Mutation Evaluation in Thyroid Nodule Screening for Malignancy: A Prospective Study 279
Chemical Composition of Essential Oils from Thymus vulgaris, Cymbopogon citratus, and Rosmarinus officinalis, and Their Effects on the HIV-1 Tat Protein Function 272
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression 268
Igf-I influences everolimus activity in medullary thyroid carcinoma 263
Relevance of BRAF(V600E) Mutation Testing Versus RAS Point Mutations and RET/PTC Rearrangements Evaluation in the Diagnosis of Thyroid Cancer 260
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 256
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 254
Everolimus as a new potential antiproliferative agent in aggressive human bronchial carcinoids 250
Proteasomes and RARS modulate AIMP1/EMAP II secretion in human cancer cell lines 247
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 246
BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies 241
Inhibition of epithelial growth factor receptor can play an important role in reducing cell growth and survival in adrenocortical tumors 236
Magmas Overexpression Inhibits Staurosporine Induced Apoptosis in Rat Pituitary Adenoma Cell Lines 234
Functional characterization of a new deletion in CDKN1B 5'-UTR region 231
Early onset acromegaly associated with a novel deletion in CDKN1B 5'UTR region 231
Allelic discrimination in the diagnosis of somatic BRAF V600E mutation on fine-needle aspiration biopsies 228
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 227
mTOR, AKT, p70S6K and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 223
Magmas, a Novel Over-Expressed Gene in Pituitary Rat Cell Lines and in Human Pituitary Adenomas: A New Pituitary Biomarker? 221
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression 219
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 217
Growth hormone excess promotes breast cancer chemoresistance 216
Growth hormone induces chemoresistance in breast cancer cells 216
Involvement of PKCβ and PKCδ isoforms in TSH signaling pathway in thyroid cancer cell lines 214
N-carbamidoyl-4-((3-ethyl-2,4,4-trimethylcyclohexyl)methyl)benzamide enhances staurosporine cytotoxic effects likely inhibiting the protective action of Magmas toward cell apoptosis 214
BRAFV600E analysis on fine needle aspiration biopsy increases diagnostic accuracy for papillary thyroid cancer in clinically unsuspected nodules 213
Cabergoline reduces cell viability in non functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 213
Identification of differentially expressed microRNAs by microarray: A possible role for microRNA genes in pituitary adenomas 210
Differential mTOR and PI3K Pathway Activation in Human Bronchial Carcinoids 207
Therapeutic concentrations of mitotane (o,p′-DDD) inhibit thyrotroph cell viability and TSH expression and secretion in a mouse cell line model 205
miR-15a and miR-16-1 down-regulation in pituitary adenomas 205
Magmas, a Gene Newly Identified as Overexpressed in Human and Mouse ACTH-Secreting Pituitary Adenomas, Protects Pituitary Cells from Apoptotic Stimuli 204
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 203
Deletion of exons 1-3 of the MEN1 gene in a large Italian family causes the loss of menin expression 203
Mitotane enhances doxorubicin cytotoxic activity by inhibiting P-gp in human adrenocortical carcinoma cells 202
R171Q MEN1 polymorphism in patients presenting with hyperparathyroidism 202
Magmas, a novel over-expressed gene in Pituitary rat cell lines and in human pituitary adenomas: a new pituitary bio marker? 199
Growth hormone receptor blockade inhibits growth hormone-induced chemoresistance by restoring cytotoxic-induced apoptosis in breast cancer cells independently of estrogen receptor expression. 197
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 191
Growth Hormone Enhances Breast Cancer Chemoresistance by Inhibiting JNK-Mediated Apoptosis 188
mTOR, p70S6K, AKT and ERK1/2 levels predict sensitivity to mTOR and PI3K/mTOR inhibitors in human bronchial carcinoids 187
Bronchial carcinoid response to mTOR inhibitors depends on mTOR expression levels 186
Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro 185
Utilization of luminescent technology to develop a kinase assay: Cdk4 as a model system 183
Effects of mTOR inhibitors in the control of non functioning pituitary adenomas cell growth 182
The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells 182
Somatostatin receptor subtype 1 selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. 181
GH enhances breast cancer chemoresistance by inhibiting JNK-mediated apoptosis 181
Caffeic Acid Enhances the Anti-Leukemic Effect of Imatinib on Chronic Myeloid Leukemia Cells and Triggers Apoptosis in Cells Sensitive and Resistant to Imatinib 181
Dopamine receptor 2 activation reduces cells viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 180
GH influences breast cancer chemoresistanec independently of cell cycle perturbations 180
Cytotoxicity of Isoxazole Curcumin Analogs on Chronic Myeloid Leukemia-Derived K562 Cell Lines Sensitive and Resistant to Imatinib 179
Everolimus reduces human ACTH-secreting pituitary adenoma in vitro cell viability 177
Role of complex Cdk4/Cyclin D1 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro 177
Role of Piuitary Tumour Transforming Gene 1 in medullary thyroid carcinoma 174
Growth Hormone enhances breast cancer chemoresistance by protecting from apoptosis 174
Cyclo-oxygenase 2 modulates chemoresistance in breast cancer cells involving NF-κB 173
Effects of pasireotide on bronchial carcinoids in primary culture 168
Characterization of Stable Pyrazole Derivatives of Curcumin with Improved Cytotoxicity on Osteosarcoma Cell Lines 167
Everolimus reduces human ACTH secreting pituitary adenoma in vitro cell viability by inhibiting IGF-I down-stream signalling 166
SHP-1 restrains cell proliferation in human medullary thyroid carcinoma 165
Somatostatin, but not somatostatin receptor subtypes 2 and 5 selective agonists, inhibits calcitonin secretion and gene expression in the human medullary thyroid carcinoma cell line, TT. 164
Evaluation of PKC isoforms expression in thyroid cells lines and effects of a PKC beta II selective inhibitor 164
Multiple somatostatin receptor subtypes activation reduces cell viability in non-functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 163
Real-time PCR is useful to detect menin gene deletions 159
Role of complex cyclin D1/Cdk4 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro 157
Thyroid Nodule Screening for Malignancy: A Prospective Study on Ultrasonographic/Clinical Profile, Cytology and BRAF V600E Mutation Evaluation 157
A Novel PKC beta II Inhibitor Induces Antiproliferative Effects in Human Pancreatic Neuroendocrine Tumor Cells 157
Somatostatin receptor subtypes 2 and 5 differentially affect proliferation in vitro of the human medullary thyroid carcinoma cell line TT 156
Selected terpenes from leaves of Ocimum basilicum L. induce hemoglobin accumulation in human K562 cells 156
Somatostatin receptor subtype 1 selective activation in human growth hormone- and prolactin-secreting pituitary adenomas: effects on cell viability, growth hormone and prolactin secretion. 154
GH protects breast cancer cells from chemotherapy by blocking cytotoxic-induced apoptosis in estrogen receptor negative breast cancer cells 154
Selective Cyclo-oxygenase 2 inhibitors revert chemoresistance In Medullary thyroid carcinoma by a mechanism mediated by P-gp and PGH2 153
mTOR inhibition influences cell viability of human bronchial carcinoids in vitro 152
Mitotane reduces human and mouse ACTH-secreting pituitary cell viability and function. 149
PGH2 blocks the chemosensitizing effects of COX-2 inhibitors by a NF-KB mediated mechanism 147
Somatostatin inhibits a medullary thyroid carcinoma cell line growth by activating SHP-1 146
PKCδ plays an important in regulating human medullary thyroid carcinoma cell viability 145
Evidence for pituitary tumour transforming gene 1 (PTTG-1) expression and its possible oncogenic role in medullary thyroid carcinoma. 144
mTOR inhibition influences cell viability of medullary thyroid carcinoma primary cultures 143
Somatostatin differentially influences proliferation and gene expression by modulating SHP-1 and cAMP pathways in a human medullary thyroid carcinoma cell line 137
A Central Contribution of TG2 Activity to the Antiproliferative and Pro-Apoptotic Effects of Caffeic Acid in K562 Cells of Human Chronic Myeloid Leukemia 134
α-Pinene, a Main Component of Pinus Essential Oils, Enhances the Expression of Insulin-Sensitive Glucose Transporter Type 4 in Murine Skeletal Muscle Cells 127
PRKCD Is a Target of miR-26a in ACTH Pituitary Adenoma 123
miR-26a regulates cell cycle in ACTH-secreting pituitary adenomas through Protein Kinase C delta 122
SSTR subtypes expression pattern influences the antiproliferative effects of somatostatin and lanreotide on human medullary thyroid carinomas in vitro 121
Targeting PKC in human pancreatic neuroendocrine tumor cells 120
IGF-I proliferative effects are inhibited by targeting PKC in human neuroendocrine tumor cells 118
Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro 115
Validation of a murine model to study deregulated pituitary microRNA 114
mTOR inhibition hampers cell viability in selected human medullary thyroid carcinoma primary cultures 113
miR-26a targets PRKCD in ACTH pituitary adenoma 109
miR-26a Plays an Important Role in Cell Cycle Regulation in ACTH-Secreting Pituitary Adenomas by Modulating Protein Kinase C  109
null 106
null 92
miR-26a and cell cycle control in ACTH secreting pituitary adenoma 82
Targeting protein kinase C by Enzastaurin restrains proliferation and secretion in human pancreatic endocrine tumors 81
Totale 18.581
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.067
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.067
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.041 37 101 68 20 47 54 48 41 36 87 113 389
2022/20231.192 110 102 63 162 191 170 74 94 134 9 49 34
2023/2024908 60 66 28 19 59 105 23 373 19 13 8 135
2024/20252.397 52 46 192 66 312 328 67 70 343 243 365 313
2025/20267.182 716 302 557 785 1.199 472 967 352 683 737 250 162
2026/2027141 141 0 0 0 0 0 0 0 0 0 0 0
Totale 18.783